Table 4.
Increased concentrations of Zn, Δ[Zn] (nmol/g), in organs of [Zn(hmpt)2]-treated mice compared with control mice (A), and increased concentrations of Zn and Se, Δ[Zn] (nmol/g) and Δ[Se] (nmol/g), and Δ[Zn]/Δ[Se] molar ratios, in organs of [Zn(hmps)2]-treated mice compared with control mice (B).
| (A) | |||||
| Plasma | Liver | Kidney | Bone | Pancreas | |
| Δ[Zn] (nmol/g) | 3 | 453 | 86 | 517 | 302 |
| (B) | |||||
| Plasma | Liver | Kidney | Bone | Pancreas | |
| Δ[Zn] (nmol/g) | 6 | 23 | 20 | 124 | 375 |
| Δ[Se] (nmol/g) | 6 | 38 | 81 | 18 | 14 |
| Δ[Zn]/Δ[Se] | 1.0 | 0.61 | 0.25 | 6.9 | 27 |
[Zn(L)]: Δ[Zn]/Δ[Se] = 1.0, [Zn(L)2]: Δ[Zn]/Δ[Se] = 0.5.